PET/CT Ga-68 DOTATATE (NETs) — Dictation, Appropriateness, and Dose for Residents

1. The DOTATATE Read: From SUVmax to Theranostic Candidacy

It’s a Tuesday afternoon. You pick up an outpatient PET/CT Ga-68 DOTATATE on a patient with a known pancreatic neuroendocrine tumor. The ordering oncologist’s note is brief but clear: “Assess for metastatic disease and PRRT candidacy.” Your attending expects a Krenning score for the dominant lesions, a clear statement on theranostic potential, and a report that doesn’t miss the classic sites of physiologic uptake. This isn’t just about finding hot spots; it’s a key decision point for peptide receptor radionuclide therapy (PRRT), and your report will guide that multi-thousand-dollar decision.

When I was a fellow, I’d keep a cheat sheet taped to my monitor with the Krenning score criteria and a list of physiologic pitfalls like the pancreatic uncinate process. Getting it right means the patient gets the right therapy. Getting it wrong means delays and confusion. This guide, and resources like those in the residents and fellows resource hub, are designed to make sure you have the framework you need before you even hit the dictate button.

2. What a PET/CT Ga-68 DOTATATE Covers and What Attendings Look For

The PET/CT Gallium-68 DOTATATE is the modern gold standard for imaging well-differentiated neuroendocrine tumors (NETs) that express somatostatin receptors (SSTRs). It has largely replaced the older, lower-resolution Indium-111 Octreoscan, offering much higher sensitivity, a lower radiation dose, and a faster workflow.

This study is primarily used for the initial staging of NETs, evaluating for recurrence, and, critically, determining if a patient is a candidate for PRRT with Lutetium-177 DOTATATE (Lutathera). The Ga-68 DOTATATE acts as the diagnostic partner in this theranostic pair: if the tumor avidly takes up the diagnostic agent, it will likely respond to the therapeutic one.

Your attending will expect a comprehensive report that methodically:

• Identifies and characterizes all sites of pathologic SSTR-avid disease.
• Quantifies uptake, typically using the Krenning score and/or SUVmax.
• Differentiates pathologic uptake from common physiologic sites (pituitary, spleen, adrenals, kidneys, bladder, and sometimes the pancreatic uncinate process).
• Evaluates the most common sites of NET metastasis: liver, lymph nodes, and bone.
• Provides a clear, concise impression that summarizes the extent of disease and explicitly states whether the findings support candidacy for PRRT.

3. Radiology Report Template for PET/CT Ga-68 DOTATATE

Use this template as a starting point for your macros. It’s structured to ensure you hit all the key points your attending and the referring oncologist need.

Technique

A PET/CT scan of the [skull base to mid-thighs/whole body] was performed approximately 60 minutes after the intravenous administration of [X] mCi of Ga-68 DOTATATE. A low-dose, non-contrast CT was performed for attenuation correction and anatomic localization. [Optional: A diagnostic-quality contrast-enhanced CT of the [chest/abdomen/pelvis] was also performed.]

Findings

COMPARISON: [Date of prior study]

PHYSIOLOGIC UPTAKE: Normal physiologic radiotracer distribution is seen in the pituitary gland, spleen, adrenal glands, liver, kidneys, and urinary bladder. Physiologic uptake is noted in the pancreatic uncinate process.

PATHOLOGIC UPTAKE:

Head and Neck: No focal pathologic SSTR-avid uptake.

Chest: No pathologic SSTR-avid mediastinal, hilar, or axillary lymphadenopathy. No SSTR-avid pleural or pulmonary lesions.

Abdomen and Pelvis:

Liver: The liver demonstrates physiologic background uptake. [Describe any focal SSTR-avid lesions, providing size, location, SUVmax, and Krenning score. Example: A 2.5 cm SSTR-avid lesion in hepatic segment 7 demonstrates intense uptake significantly greater than the spleen, with an SUVmax of 25.4 (Krenning score 4).]

Pancreas: [Describe primary tumor if present. Example: The previously seen 3.1 cm mass in the pancreatic tail demonstrates intense SSTR avidity, with an SUVmax of 30.1 (Krenning score 4).]

Adrenal Glands: Symmetric physiologic uptake. No focal SSTR-avid adrenal mass.

Lymph Nodes: [Describe any SSTR-avid lymphadenopathy. Example: SSTR-avid retroperitoneal lymph nodes are present, the largest measuring 1.8 cm with an SUVmax of 15.2 (Krenning score 3).]

Other: [Describe any other sites of disease.]

Bones/Musculoskeletal: No SSTR-avid osseous metastases.

Impression

1. Evidence of somatostatin receptor (SSTR)-avid metastatic neuroendocrine tumor, as described above. Key sites of disease include:
   • [Location, e.g., Pancreatic tail primary]
   • [Location, e.g., Multiple hepatic metastases]
   • [Location, e.g., Retroperitoneal lymphadenopathy]
2. The majority of lesions demonstrate intense radiotracer uptake with Krenning scores of 3 or 4 (uptake greater than or equal to liver), consistent with high SSTR expression.
3. These findings support the patient’s candidacy for peptide receptor radionuclide therapy (PRRT) with Lu-177 DOTATATE.

4. Free Template Sources for Residents

Building a personal macro library is a rite of passage. If you’re looking for more templates across different modalities and subspecialties, two great free repositories exist. These are excellent, community-driven resources worth bookmarking.

• RadReport.org: Curated by the RSNA, this is a massive and reliable library of peer-reviewed templates.
• Radiology Templates (AU): An excellent, well-organized collection maintained by Australian radiologists with a practical, clinically-focused approach.

5. The Next-Level Move: AI-Assisted Structured Reporting

A solid template is your foundation. The next step is making the reporting process faster and more consistent, especially when you have a complex case with multiple positive findings. Instead of manually slotting each measurement and score into your template, you can dictate your findings in free form and let an AI tool handle the structuring.

For example, you’d simply dictate, “Multiple hypermetabolic liver lesions, the largest in segment 4a is 3 cm with SUVmax of 22, uptake greater than spleen. Another 2 cm lesion in segment 6, SUV 18. Avid retroperitoneal node, 1.5 cm, SUV 12.” The AI then parses this, populates the structured findings section with the correct locations and measurements, assigns a Krenning score, and drafts the appropriate PRRT candidacy statement in the impression.

This is the core function of tools like GigHz Precision AI. It’s designed to take your expert observations, spoken naturally, and generate a clean, attending-ready structured report based on ACR and society guidelines. It helps ensure key elements like theranostic implications are never missed.

6. When Should You Order a PET/CT Ga-68 DOTATATE? ACR Appropriateness Criteria

The American College of Radiology (ACR) provides guidance on neuroendocrine imaging. While Ga-68 DOTATATE is the workhorse for systemic NETs, the ACR Appropriateness Criteria for “Neuroendocrine Imaging” focus heavily on pituitary and sellar pathology, which can also express somatostatin receptors.

For an adult with a suspected or known hyperfunctioning pituitary adenoma (e.g., causing Cushing syndrome or acromegaly), or for surveillance after resection of a pituitary mass, advanced imaging is considered “Usually Appropriate.” Similarly, for initial imaging of diabetes insipidus or pituitary apoplexy, imaging is “Usually Appropriate.” In children presenting with precocious puberty, initial imaging is also “Usually Appropriate.”

While MRI is often the first-line modality for pituitary evaluation, PET/CT DOTATATE can be a powerful problem-solving tool, especially for recurrent meningiomas or other SSTR-expressing sellar masses.

For poorly differentiated or high-grade NETs, an FDG PET/CT is often more appropriate, as these aggressive tumors tend to lose SSTR expression and become more metabolically active. For anatomic detail without functional information, a contrast-enhanced CT or MRI remains a viable alternative.

7. How Much Radiation Does a PET/CT Ga-68 DOTATATE Deliver?

A combined PET/CT with Ga-68 DOTATATE delivers an estimated effective radiation dose of 5-10 mSv.

This dose comes from two sources: the injected radiotracer (Ga-68 DOTATATE) and the low-dose CT scan used for localization and attenuation correction. To put this in perspective, this is comparable to a few years of natural background radiation. It is a significantly lower dose than the older Indium-111 Octreoscan it replaced. The protocol is designed to be “as low as reasonably achievable” (ALARA) while maintaining excellent diagnostic quality for detecting SSTR-positive tumors.

8. PET/CT Ga-68 DOTATATE Imaging Protocol — Phases, Contrast, and Key Parameters

The DOTATATE protocol is standardized to ensure optimal tumor-to-background contrast and accurate quantification. The process begins with intravenous injection of the tracer, followed by a 60-minute uptake period where the patient rests quietly. This allows the Ga-68 DOTATATE to bind to somatostatin receptors on tumor cells throughout the body.

Following the uptake phase, the patient is positioned on the scanner. A low-dose CT is acquired first, which serves two purposes: it provides the anatomical map onto which the PET data is fused, and it generates an attenuation map to correct the PET signal. Finally, the PET data is acquired over 5-7 bed positions, covering the patient from the skull base to the mid-thighs.

Common Protocol Pitfalls: The most critical pitfall is interference from somatostatin analog therapy (octreotide). Short-acting octreotide should be held for at least 24 hours, and long-acting formulations must be held for at least 4 weeks prior to the scan to prevent competitive binding and a potential false-negative result.

9. The 3-Months-Free Offer for Radiology Residents and Fellows

3+ months free for radiology residents and fellows

Look like a rockstar on your reports — dictate positive findings in free form, and the AI generates a structured report using ACR + SIR templates with the appropriate clinical decision support firing automatically. All we ask is feedback so we can keep improving the product for trainees.

Signup is simple. No credit card, no long forms. To get set up, just provide these three items:

1. Your PGY year (e.g., PGY-2, PGY-4)
2. Your training type (radiology residency or specific fellowship — IR, body, MSK, neuro, peds, breast, nucs)
3. Your training program / hospital name
4. (Optional) Your institutional email

Ready to try it? Apply for the residents free-access program and we’ll get you set up.

10. Frequently Asked Questions

Is GigHz Precision AI HIPAA-compliant?

Yes. The platform is designed for de-identified workflows by default. It operates on the anonymized text of your dictation and does not require access to protected health information (PHI) or your hospital’s EMR or PACS to function.

Do I need my hospital’s IT department to set this up?

No. GigHz Precision AI is browser-based and requires no local software installation or special permissions. It works on any modern web browser, including the one on your call-room workstation or personal iPad.

Does it work with PowerScribe or other dictation systems?

Yes. It works alongside any dictation system. You dictate as you normally would. You can then paste your free-form text into the tool to get a structured report back, which you can copy into your final sign-off window. It’s a workflow enhancement, not a replacement for your core dictation software.

Can I customize the templates?

Yes. While the system comes pre-loaded with templates based on ACR and other society guidelines, you can customize them to match your institution’s or your personal preferences for wording and structure.

What happens after I finish residency or fellowship?

The free access program is specifically for trainees. After you graduate, you can transition to a standard individual or group plan. Many alumni continue to use the tool in their private and academic practices.

Free GigHz Tools That Pair With This Article

Three free tools that complement the material above:

• ACR Appropriateness Criteria Lookup — Type an indication or clinical scenario in plain language and get the imaging studies the ACR rates for it, with adult and pediatric radiation levels. Built directly from 297 ACR topics, 1,336 clinical variants, and 15,823 procedure ratings.
• GigHz Imaging Protocol Library — A searchable library of 131 imaging protocols with the physics specs surfaced and the matching ACR Appropriateness Criteria alongside. Plain-English narratives readable in 60 seconds, organized by modality.
• GigHz Radiation Dose Calculator — Pick the imaging studies a patient has had and see total dose in millisieverts (mSv) with comparisons to natural background radiation, transatlantic flights, and chest X-rays. Useful for shared decision-making.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 7, 2026